Previous 10 | Next 10 |
Thorne HealthTech press release (NASDAQ:THRN): Q4 Non-GAAP EPS of $0.07. Revenue of $49.9M. For further details see: Thorne HealthTech Non-GAAP EPS of $0.07, revenue of $49.9M
Thorne HealthTech Reports Fourth Quarter and Full-Year 2021 Results PR Newswire Provides Full-Year 2022 Guidance NEW YORK , March 14, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or the "Company") (NASDAQ: THRN), a leader...
Wellness company Thorne HealthTech (NASDAQ:THRN) has acquired Nutrativa, a company that leverages 2D printing technology to offer environmentally superior alternatives to traditional beverages and gummies via dissolvable supplement discs. Terms of the deal were not disclosed. The acquisition ...
Thorne HealthTech Announces the Acquisition of Nutrativa Acquisition of Nutrativa and its high-speed printing technology will enable Thorne HealthTech to add quick-dissolving supplement discs to its product offerings Products are environmentally superior alternatives, helpin...
Thorne HealthTech Announces Fourth Quarter and Full-Year 2021 Earnings Conference Call PR Newswire NEW YORK , Feb. 25, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to hea...
Thorne Health Tech (NASDAQ:THRN) and Ultimate Fighting Championship (UFC) announced a multi-year extension of their global marketing partnership. THRN remains the Official Sports Performance Nutrition Partner of UFC and an official partner of the UFC Performance Institute, the world's first M...
UFC® AND THORNE ANNOUNCE MULTI-YEAR EXTENSION OF PARTNERSHIP Thorne to Continue as Official Sports Performance Nutrition Partner of UFC PR Newswire LAS VEGAS and NEW YORK , Feb. 24, 2022 /PRNewswire/ -- UFC ® , the world's premier mixed ...
Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement Canada NewsWire OTTAWA, ON , Feb. 22, 2022 /CNW/ - Tetra Bio-Pharma Inc (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cann...
Thorne HealthTech and Mitsui Announce Thorne Asia Joint Venture Thorne Asia will drive awareness and growth of healthy aging products Joint venture is well-positioned to capitalize on unmet market needs with offering that includes diagnostics, analytics and supplements to su...
Thorne HealthTech's First-of-Its-Kind 'Wellth Report' Reveals Shifts in Individuals' Health Behaviors with Ripple Effects for the Healthcare Industry and Broader Workforce The 2021 Wellth Report explores how the needs of consumers have changed due to the pandemic, specifically r...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...